CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE

This adverse event was reported 55 times

These drugs are most commonly taken by patients reporting CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE:

# Drug Count
0 RITUXIMAB 16
1 METHOTREXATE 15
2 METHOTREXATE SODIUM 15
3 NINTEDANIB 14
4 PREDNISONE 13
5 FUROSEMIDE 11
6 TACROLIMUS 11
7 TACROLIMUS EXTENDED-RELEASE CAPSULES 11
8 TACROLIMUS OINTMENT 0.1% 11
9 IBUPROFEN 10
See all common drugs associated with CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE

CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 1 0.0769
1 NYSTATIN TOPICAL POWDER 1 0.0312
2 BARICITINIB 9 0.0029
3 ADALIMUMAB-ATTO 1 0.0006
4 TESTOSTERONE UNDECANOATE 1 0.0005
5 NINTEDANIB 14 0.0004
6 RITUXIMAB-ABBS 2 0.0004
7 VANCOMYCIN HYDROCHLORIDE 3 0.0004
8 MYCOPHENILIC ACID 4 0.0002
9 BETAMETHASONE DIPROPIONATE 1 0.0001
See all drugs enriched for association with CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE